全文获取类型
收费全文 | 4644篇 |
免费 | 457篇 |
国内免费 | 1篇 |
出版年
2023年 | 18篇 |
2022年 | 13篇 |
2021年 | 148篇 |
2020年 | 81篇 |
2019年 | 77篇 |
2018年 | 122篇 |
2017年 | 107篇 |
2016年 | 162篇 |
2015年 | 292篇 |
2014年 | 293篇 |
2013年 | 342篇 |
2012年 | 385篇 |
2011年 | 392篇 |
2010年 | 268篇 |
2009年 | 211篇 |
2008年 | 290篇 |
2007年 | 291篇 |
2006年 | 264篇 |
2005年 | 185篇 |
2004年 | 189篇 |
2003年 | 182篇 |
2002年 | 163篇 |
2001年 | 49篇 |
2000年 | 44篇 |
1999年 | 52篇 |
1998年 | 41篇 |
1997年 | 22篇 |
1996年 | 17篇 |
1995年 | 24篇 |
1994年 | 23篇 |
1993年 | 21篇 |
1992年 | 31篇 |
1991年 | 24篇 |
1990年 | 27篇 |
1989年 | 19篇 |
1988年 | 16篇 |
1987年 | 12篇 |
1986年 | 17篇 |
1985年 | 14篇 |
1984年 | 17篇 |
1983年 | 14篇 |
1982年 | 18篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1976年 | 7篇 |
1973年 | 8篇 |
1969年 | 5篇 |
排序方式: 共有5102条查询结果,搜索用时 31 毫秒
81.
82.
Walter E. Bollenbacher Wayne V. Vedeckis Lawrence I. Gilbert John D. OConnor 《Developmental biology》1975,44(1):46-53
The titer of ecdysone in whole animal extracts of Manduca sexta was determined by radioimmunoassay during the fifth (last) larval instar, pharate pupal development and pupation. A subtle peak in ecdysone concentration was noted at day 4 (just prior to the onset of the wandering stage) and a second and greater peak at day 8.5 (coincident with pharate pupal development). The titer fluctuations during development were a result of changes in tissue ecdysone and not of alterations in the ecdysone content of the gut. When prothoracic gland secretory activity was analyzed in vitro at the same stages, the most rapid rate of α-ecdysone secretion was shown to occur on day 7 (one day prior to the peak in whole-animal ecdysone concentration). An earlier peak in prothoracic gland activity may occur at day 4–5. Thin layer and gas-liquid chromatographic analyses revealed developmental changes in the ratio of β:α-ecdysone in hemolymph and whole-animal extracts. It is suggested that the steroid-hydroxylating capacity of the insect increases during the instar. 相似文献
83.
84.
Bonnie L. Barrilleaux Benjamin W. Fischer-Valuck Jennifer K. Gilliam Donald G. Phinney Kim C. O’Connor 《In vitro cellular & developmental biology. Animal》2010,46(6):566-572
Therapeutic administration of mesenchymal stem cells (MSCs) by systemic delivery utilizes the innate ability of the cells to home to damaged tissues, but it can be an inefficient process due to a limited knowledge of cellular cues that regulate migration and homing. Our lab recently discovered that a potent pro-inflammatory cytokine, macrophage migration inhibitory factor (MIF), inhibits MSC migration. Because MIF may act on multiple cellular targets, an activating antibody (CD74Ab) was employed in this study to examine the effect of one MIF receptor, CD74 (major histocompatibility complex class II-associated invariant chain), on MSC motility. CD74 activation inhibits in a dose-dependent manner up to 90% of in vitro migration of MSCs at 40 μg/ml CD74Ab (p?<?0.001), with consistent effects observed among three MSC donor preparations. A blocking peptide from the C-terminus of CD74 eliminates the effect of CD74Ab on MSCs. This suggests that MIF may act on MSCs, at least in part, through CD74. Late-passage MSCs exhibit less chemokinesis than those at passage 2. However, MSCs remain responsive to CD74 activation during ex vivo expansion: MSC migration is inhibited ~2-fold in the presence of 5 µg/ml CD74Ab at passage 9 vs. ~3-fold at passage 2 (p?<?0.001). Consistent with this result, there were no significant differences in CD74 expression at all tested passages or after CD74Ab exposure. Targeting CD74 to regulate migration and homing potentially may be a useful strategy to improve the efficacy of a variety of MSC therapies, including those that require ex vivo expansion. 相似文献
85.
86.
Within 48 h of administration of radiolabelled 10-formylfolate, folic acid and the polyglutamate derivative 10-formylfolate tetraglutamate to the rat, fragmentation products are found in the urine. The major catabolite was identified as p-acetamidobenzoate by chromatography and reverse isotope-dilution analysis. 相似文献
87.
Xiuhua Li Laney Redus Cang Chen Paul A. Martinez Randy Strong Senlin Li Jason C. O’Connor 《PloS one》2013,8(8)
Parkinson’s disease (PD) is a neurodegenerative disorder primarily characterized by progressive loss of dopamine neurons, leading to loss of motor coordination. However, PD is associated with a high rate of non-motor neuropsychiatric comorbities that often develop before the onset of movement symptoms. The MitoPark transgenic mouse model is the first to recapitulate the cardinal clinical features, namely progressive neurodegeneration and death of neurons, loss of motor function and therapeutic response to L-DOPA. To investigate whether MitoPark mice exhibit early onset of cognitive impairment, a non-motor neuropsychiatric comorbidity, we measured performance on a spatial learning and memory task before (∼8 weeks) or after (∼20 weeks) the onset of locomotor decline in MitoPark mice or in littermate controls. Consistent with previous studies, we established that a progressive loss of spontaneous locomotor activity began at 12 weeks of age, which was followed by progressive loss of body weight beginning at 16–20 weeks. Spatial learning and memory was measured using the Barnes Maze. By 20 weeks of age, MitoPark mice displayed a substantial reduction in overall locomotor activity that impaired their ability to perform the task. However, in the 8-week-old mice, locomotor activity was no different between genotypes, yet MitoPark mice took longer, traveled further and committed more errors than same age control mice, while learning to successfully navigate the maze. The modest between-day learning deficit of MitoPark mice was characterized by impaired within-day learning during the first two days of testing. No difference was observed between genotypes during probe trials conducted one or twelve days after the final acquisition test. Additionally, 8-week-old MitoPark mice exhibited impaired novel object recognition when compared to control mice. Together, these data establish that mild cognitive impairment precedes the loss of motor function in a novel rodent model of PD, which may provide unique opportunities for therapeutic development. 相似文献
88.
89.
Loree Heller Reynald Thinard Melanie Chevalier Sezgi Arpag Yu Jing Ruth Greferath Richard Heller Claude Nicolau 《Journal of cellular and molecular medicine》2020,24(15):8772-8778
In neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis, neuroinflammation can lead to blood‐brain barrier (BBB) breakdown. After intravenous or intra‐arterial injection into mice, endothelial progenitor cells (EPCs) home to the damaged BBB to promote neurovascular repair. Autologous EPCs transfected to express specific therapeutic proteins offer an innovative therapeutic option. Here, we demonstrate that EPC transfection by electroporation with plasmids encoding the reporter protein GFP or an anti‐β‐amyloid antibody fragment (Fab) leads to secretion of each protein. We also demonstrate the secreted anti‐β‐amyloid Fab protein functions in β‐amyloid aggregate solubilization. 相似文献
90.
Schlacher Thomas A. Gilby Ben L. Olds Andrew D. Henderson Christopher J. Connolly Rod M. Peterson Charles H. Voss Christine M. Maslo Brooke Weston Michael A. Bishop Melanie J. Rowden Ashley 《Ecosystems》2020,23(4):906-916
Ecosystems - Ecotones can form hot spots of biodiversity by containing species from multiple ecosystems. Because biodiversity is often linked to ecological function, we posit that rates of key... 相似文献